Chk1 inhibition after replicative stress activates a double strand break response mediated by ATM and DNA-dependent

Samuel McNeely1, Chiara Conti, Tahir Sheikh

  • 1Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY, USA.

Insights

Inhibiting Checkpoint kinase 1 (Chk1) with AZD7762 enhances gemcitabine chemotherapy by destabilizing replication forks and causing DNA breaks. This combination therapy may be effective against tumors with DNA repair defects.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Checkpoint kinase 1 (Chk1) is crucial for cell cycle checkpoints and DNA repair following genotoxic stress.
  • Inhibiting Chk1 is a promising strategy to enhance chemotherapy efficacy.
  • AZD7762 is an ATP-competitive inhibitor targeting Chk1/2 kinases.

Purpose of the Study:

  • To investigate the mechanisms by which AZD7762 potentiates gemcitabine cytotoxicity.
  • To identify the specific DNA damage response pathways involved in AZD7762 and gemcitabine combination therapy.
  • To explore the potential of this combination therapy in specific cancer types.

Main Methods:

  • Treatment of cells with AZD7762 and gemcitabine.
  • Analysis of replication fork dynamics and stability using DNA fiber combing.
  • Measurement of DNA breaks via comet assay.
  • Assessment of kinase involvement (ATM, DNA-PK, ATR) in gammaH2AX induction.
  • Evaluation of sensitivity in cells deficient in DNA double-strand break (DSB) repair.
  • Monitoring cell cycle progression and mitotic entry.
  • Investigation of apoptosis induction and prevention.

Main Results:

  • AZD7762 induces gammaH2AX in gemcitabine-treated cells by altering replication fork dynamics and stability.
  • ATM and DNA-PK, not ATR, mediate gammaH2AX induction, suggesting conversion of stalled forks to DSBs.
  • Cells deficient in DSB repair (BRCA2, XRCC3, DNA-PK) show increased sensitivity to the combination therapy.
  • AZD7762 causes premature mitosis in gemcitabine-treated cells, leading to apoptosis.
  • Combination therapy involves origin firing activation, replication fork destabilization, and entry into lethal mitosis.

Conclusions:

  • Chemosensitization by Chk1 inhibition involves multiple cellular events: origin firing, replication fork collapse, and premature mitotic entry.
  • The combination of AZD7762 and gemcitabine may be particularly effective in tumors with defects in DNA repair pathways.
  • Targeting Chk1 offers a viable strategy to overcome gemcitabine resistance and enhance anti-cancer effects.

Related Concept Videos

DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Restarting Stalled Replication Forks02:37

Restarting Stalled Replication Forks

DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart, a...
Homologous Recombination02:31

Homologous Recombination

The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.
S-Cdk Initiates DNA Replication02:38

S-Cdk Initiates DNA Replication

The cell cycle is a series of events leading to DNA duplication followed by the division of cell content to form two daughter cells. The cell cycle progresses in four stages—the cell increases in size (gap 1 or G1-phase), duplicates its DNA (synthesis or S-phase), prepares to divide (gap 2 or G2-phase), and divides (mitosis or M-phase).
Two states at the origin of replication
In eukaryotes, the initiation of replication occurs at many sites on the chromosomes, called the origins of replication.